Medicofarma Biotech SA (WSE:MDB)
Poland flag Poland · Delayed Price · Currency is PLN
0.4880
+0.0080 (1.67%)
At close: Apr 16, 2026

Medicofarma Biotech Balance Sheet

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
00.010.010.510.08
Cash & Short-Term Investments
00.010.010.510.08
Cash Growth
-72.08%19.22%-98.97%556.50%20.91%
Accounts Receivable
1.450.480.380.371.42
Other Receivables
3.673.332.131.240.03
Receivables
5.113.82.511.611.45
Inventory
-000.140.56
Total Current Assets
5.113.812.522.262.08
Property, Plant & Equipment
9.0310.5512.0912.5612.7
Other Intangible Assets
0.050.10.151.541.98
Long-Term Deferred Tax Assets
-0.240.21--
Other Long-Term Assets
0.010.01-0.01-
Total Assets
14.214.7114.9716.3716.77
Accounts Payable
1.221.291.191.341.47
Accrued Expenses
0.481.562.261.110.44
Short-Term Debt
000--
Current Income Taxes Payable
2.231.50.530.140.06
Other Current Liabilities
0.150.130.040.690.12
Total Current Liabilities
4.094.494.023.282.08
Long-Term Debt
3.712.531.39--
Other Long-Term Liabilities
0.720.820.380.480.48
Total Liabilities
8.527.845.83.762.56
Common Stock
6.86.86.86.86.8
Additional Paid-In Capital
8.958.958.958.958.95
Retained Earnings
-10.06-8.87-6.57-3.13-1.54
Shareholders' Equity
5.686.879.1812.6114.2
Total Liabilities & Equity
14.214.7114.9716.3716.77
Total Debt
3.712.531.39--
Net Cash (Debt)
-3.71-2.53-1.390.510.08
Net Cash Growth
---556.50%-
Net Cash Per Share
-0.05-0.04-0.020.010.00
Filing Date Shares Outstanding
67.9867.9867.9867.9867.98
Total Common Shares Outstanding
67.9867.9867.9867.9867.98
Working Capital
1.02-0.68-1.5-1.01-0
Book Value Per Share
0.080.100.130.190.21
Tangible Book Value
5.646.789.0211.0812.22
Tangible Book Value Per Share
0.080.100.130.160.18
Land
0.520.520.520.520.52
Buildings
5.065.065.065.065.06
Machinery
9.019.019.018.117.34
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.